Tissue-resident T cells, in situ immunity and transplantation.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and preclinical concepts with no new empirical data.
PubMed 24517432 · doi:10.1111/imr.12149
What was done
This narrative review synthesizes preclinical and human literature regarding the properties of non-circulating tissue-resident memory T cells (Trm cells) localized in peripheral organs such as lungs, intestines, liver, and skin. It examines their compartmentalization, their role relative to circulating T cells in allograft rejection and protective post-transplant immunity, and their differential susceptibility or resistance to immunosuppressive therapies.
What was found
The abstract provides a conceptual synthesis without quantitative data or statistical metrics. It describes how resident T cells form a distinct population from circulating or secondary lymphoid T cells, playing potential dual roles as drivers of localized graft rejection and mediators of in situ protective immunity against infection, while exhibiting variable responses to standard immunosuppressive regimens.
Why it matters
Traditional transplant immunology focuses primarily on circulating and lymphoid T cells. Accounting for tissue-resident T cells could guide targeted immunosuppressive therapies designed to inhibit pathogenic graft-destructive subsets while preserving localized protective immunity.
Limits
The abstract reports no systematic review methodology, meta-analytic pooling, or original empirical data. Clinical conclusions rely on extrapolations from mechanistic studies and animal models that require further validation in human transplant recipients.
Cited by
- supports Tissue-resident T cells permanently reside within specific tissues to provide localized protection rather than circulating continuously through blood and lymphatics.